Abstract: The present invention may provide an organic electroluminescent device which exhibits low driving voltage as well as high efficiency by including an electron transporting layer material having an improved electron transporting ability.

Abstract: Provided is a pharmaceutical composition for preventing or treating osteoarthritis, the pharmaceutical composition including, as an active ingredient, obtusifolin, a derivative thereof, or a pharmaceutically acceptable salt thereof. The composition according to an aspect inhibits cartilage destruction-promoting factors and alleviates inflammatory responses, thereby exhibiting significantly excellent effects for preventing or treating osteoarthritis.

Abstract: The structure of a semiconductor device with passivation layers on active regions of FET devices and a method of fabricating the semiconductor device are disclosed. The semiconductor device includes a substrate, first and second source/drain (S/D) regions disposed on the substrate, nanostructured channel regions disposed between the first and second S/D regions, a passivation layer, and a nanosheet (NS) structure wrapped around the nanostructured channel regions. Each of the S/D regions have a stack of first and second semiconductor layers arranged in an alternating configuration and an epitaxial region disposed on the stack of first and second semiconductor layers.

Abstract: A display device includes: a display panel; a driving voltage generator; a power voltage generator; an input voltage generator; and a timing controller. The display panel is provided with a pixel configured to emit light by using a driving voltage. The driving voltage generator is configured to supply the driving voltage to the pixel. The power voltage generator is configured to generate power voltages for driving of the display panel by using an input voltage, and generating an input voltage sensing value by sensing the input voltage. The input voltage generator is configured to supply the input voltage to the power voltage generator. The timing controller is configured to control an operation of at least one of the driving voltage generator, the power voltage generator, and the input voltage generator according to the input voltage sensing value.

Abstract: The present invention relates to a novel organic compound and an organic electroluminescent device using the same, and more particularly, to a novel compound having excellent electron transport capability and light emitting capability, and an organic electroluminescent device improved in terms of luminous efficiency, driving voltage, lifespan, etc. by including the novel compound in one or more organic layers.

Abstract: Provided are a new compound for photothermal cancer therapy, a composition including the same, and a method for photothermal cancer therapy, and more particularly, a compound that is an organic photosensitizer based on an indan structure, a nanoparticle as a self-assembly thereof, a composition including the same, and a method for photothermal therapy using the same.

Abstract: A method for correcting a magnetic resonance imaging error using a heart rate interval may include: measuring T1 of a stand-alone phantom for correcting the error; obtaining a T1 map generated by mapping a recovery time according to a reference recovery rate of protons in heart tissues of a subject inverted by a radio frequency (RF) pulse in pixel units into a two-dimensional space; calculating a correction function based on the measured T1 of the phantom; and correcting an error of the T1 map based on the calculated correction function.

Abstract: An embodiment of the disclosure discloses an electronic device including at least one camera module to capture an image based on a specified angle of view, a display to display the image, a processor electrically connected with the camera module and the display. The processor detects a plurality of objects in the image, and performs setting of image data associated with at least one object of the plurality of objects such that a region, which corresponds to the at least one object, in a screen region of the display has a specified light transmittance value. Moreover, various embodiment found through the disclosure are possible.

Abstract: The present disclosure relates to a novel compound for photodynamic therapy of cancer, a composition including the same, and a method for photodynamic therapy of cancer, and more specifically, a novel photosensitizer compound based on Nplmidazole having a C?S functional group introduced, a composition and sensor including the same and a method for photodynamic therapy using the same.

Abstract: The present disclosure relates to a novel compound having an antibacterial function against superbacteria and a hypochlorous acid selective detection function, and a composition and a fluorescent sensor which comprise the same, and more particularly to, a novel imidazoline-2-thione based compound, a composition comprising the same, and a fluorescent sensor for bacterial detection and hypochlorous acid selective detection.

Abstract: A method for correcting a magnetic resonance imaging error using a heart rate interval may include: measuring T1 of a stand-alone phantom for correcting the error; obtaining a T1 map generated by mapping a recovery time according to a reference recovery rate of protons in heart tissues of a subject inverted by a radio frequency (RF) pulse in pixel units into a two-dimensional space; calculating a correction function based on the measured T1 of the phantom; and correcting an error of the T1 map based on the calculated correction function.

Abstract: An embodiment of the disclosure discloses an electronic device including at least one camera module to capture an image based on a specified angle of view, a display to display the image, a processor electrically connected with the camera module and the display. The processor detects a plurality of objects in the image, and performs setting of image data associated with at least one object of the plurality of objects such that a region, which corresponds to the at least one object, in a screen region of the display has a specified light transmittance value. Moreover, various embodiment found through the disclosure are possible.

Abstract: An embodiment of the disclosure discloses an electronic device including at least one camera module to capture an image based on a specified angle of view, a display to display the image, a processor electrically connected with the camera module and the display. The processor detects a plurality of objects in the image, and performs setting of image data associated with at least one object of the plurality of objects such that a region, which corresponds to the at least one object, in a screen region of the display has a specified light transmittance value. Moreover, various embodiment found through the disclosure are possible.

Abstract: The present invention relates to a method for constructing an Fv library based on a combination of proteins, a method of screening a desired antibody using the constructed Fv library, an Fv antibody screened by the screening method, and an Fv library constructed by the Fv library construction method. The Fv library of the present invention is based on a combination of proteins so that members thereof can be individually analyzed for their function. Moreover, the Fv library enables a desired Fv antibody to be screened without needing a target antigen preparation. In addition, the protein combination based Fv library makes it possible to significantly reduce the number of protein purification processes to thereby reduce costs and time, compared to conventional DNA-based libraries.

Abstract: An embodiment of the disclosure discloses an electronic device including at least one camera module to capture an image based on a specified angle of view, a display to display the image, a processor electrically connected with the camera module and the display. The processor detects a plurality of objects in the image, and performs setting of image data associated with at least one object of the plurality of objects such that a region, which corresponds to the at least one object, in a screen region of the display has a specified light transmittance value. Moreover, various embodiment found through the disclosure are possible.

Abstract: The present invention relates to a method for constructing an Fv library based on a combination of proteins, a method of screening a desired antibody using the constructed Fv library, an Fv antibody screened by the screening method, and an Fv library constructed by the Fv library construction method. The Fv library of the present invention is based on a combination of proteins so that members thereof can be individually analyzed for their function. Moreover, the Fv library enables a desired Fv antibody to be screened without needing a target antigen preparation. In addition, the protein combination based Fv library makes it possible to significantly reduce the number of protein purification processes to thereby reduce costs and time, compared to conventional DNA-based libraries.

Abstract: The present invention relates to a method for constructing an Fv library based on a combination of proteins, a method of screening a desired antibody using the constructed Fv library, an Fv antibody screened by the screening method, and an Fv library constructed by the Fv library construction method. The Fv library of the present invention is based on a combination of proteins so that members thereof can be individually analyzed for their function. Moreover, the Fv library enables a desired Fv antibody to be screened without needing a target antigen preparation. In addition, the protein combination based Fv library makes it possible to significantly reduce the number of protein purification processes to thereby reduce costs and time, compared to conventional DNA-based libraries.

Abstract: Disclosed herein is a skin-whitening cosmetic composition containing an extract of Magnolia sieboldii as an active ingredient. The Magnolia sieboldii extract has an excellent effect of inhibiting tyrosinase activity and melanin production, and the cosmetic composition containing the Magnolia sieboldii extract as an active ingredient has an excellent skin-whitening effect.

Abstract: Disclosed herein is a skin-whitening cosmetic composition containing an extract of Magnolia sieboldii as an active ingredient. The Magnolia sieboldii extract has an excellent effect of inhibiting tyrosinase activity and melanin production, and the cosmetic composition containing the Magnolia sieboldii extract as an active ingredient has an excellent skin-whitening effect.

Abstract: Disclosed herein is a skin-whitening cosmetic composition comprising an extract of Magnolia sieboldii as an active ingredient. The Magnolia sieboldii extract has an excellent effect of inhibiting tyrosinase activity and melanin production, and the cosmetic composition comprising the Magnolia sieboldii extract as an active ingredient has an excellent skin-whitening effect.